Zomedica Corp. (NASDAQ:ZOM) | WebDisclosure

Basculer en Français

9775	Companies
195646	Keywords
126647	Articles
104015	Press releases

Home
Companies
Zomedica Corp.

PRESS RELEASE

published on 11/11/2025 at 12:30, 2 months 19 days ago

Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
Zomedica to host special webinar session providing strategic context for product platforms. Register for the November event at https://sholink.to/NovemberFriday

Diagnostic Solutions Webinar Zomedica Animal Health Strategic Context
BRIEF

published on 11/06/2025 at 12:35, 2 months 24 days ago

Zomedica obtient la certification ISO 13485 pour l'amélioration de ses opérations

Stratégie De Croissance Efficacité Opérationnelle Certification ISO 13485 Préparation Au Marché Mondial Systèmes De Qualité
BRIEF

published on 11/06/2025 at 12:35, 2 months 24 days ago

Zomedica Secures ISO 13485 Certification for Operational Enhancement

Growth Strategy Operational Efficiency Quality Systems ISO 13485 Certification Global Market Readiness
PRESS RELEASE

published on 11/06/2025 at 12:30, 2 months 24 days ago

Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
Zomedica achieves ISO 13485 certification, bolstering quality systems, compliance, and global expansion strategy for animal health products

Certification Zomedica Global Market Animal Health ISO 13485
BRIEF

published on 11/04/2025 at 22:22, 2 months 25 days ago

Zomedica Reports Record Revenue Growth in Q3 2025

Diagnostic Products Q3 2025 Financials Zomedica Revenue Animal Health Growth Development Services
BRIEF

published on 11/04/2025 at 22:22, 2 months 25 days ago

Zomedica annonce une croissance record de son chiffre d'affaires au troisième trimestre 2025

Produits De Diagnostic Résultats Financiers Du Troisième Trimestre 2025 Revenus De Zomedica Croissance En Santé Animale Services De Développement
PRESS RELEASE

published on 11/04/2025 at 22:17, 2 months 25 days ago

Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Zomedica Corp. reports highest quarterly revenue ever and 19th consecutive year-over-year revenue growth, achieving $8.1M in sales. Record Diagnostics and Therapeutic Device segment performance drive success

Zomedica Corp. Diagnostics Therapeutic Devices Highest Revenue 19th Quarter Growth
BRIEF

published on 10/23/2025 at 12:35, 3 months 7 days ago

Zomedica Launches the Assisi Loop Lounge for Pet Therapy

Zomedica Animal Health Veterinary Innovation Assisi Loop Lounge TPEMF Therapy
BRIEF

published on 10/23/2025 at 12:35, 3 months 7 days ago

Zomedica lance l'Assisi Loop Lounge pour la zoothérapie

Zomedica Santé Animale Innovation Vétérinaire Salon Assisi Loop Thérapie TPEMF
PRESS RELEASE

published on 10/23/2025 at 12:30, 3 months 7 days ago

Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Zomedica launches the Assisi Loop Lounge, a small animal tPEMF therapy bed offering full-body treatment and comfort, backed by peer-reviewed science and a lifetime warranty

Zomedica Veterinary Innovation Assisi Loop Lounge TPEMF Therapy Pet Comfort

Accesswire

Published on 01/30/2026 at 14:00, 2 hours 3 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 28 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 3 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 13 hours 48 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 3 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 15:58, 4 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc
Published on 01/30/2026 at 15:57, 5 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/30/2026 at 15:56, 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 01/30/2026 at 15:55, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 01/30/2026 at 15:55, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc

Les Echos

Published on 01/30/2026 at 08:30, 7 hours 33 minutes ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
Published on 01/30/2026 at 08:00, 8 hours 3 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/30/2026 at 08:00, 8 hours 3 minutes ago

AMA : Chiffre d'affaires du 4ème trimestre et de l'année 2025
Published on 01/29/2026 at 18:30, 21 hours 33 minutes ago

ALPOU - Groupe POULAILLON chiffre d'affaires trimestriel T1 2025-2026 et Focus sur les activités
Published on 01/29/2026 at 18:07, 21 hours 55 minutes ago

CDA - Mise à disposition de l'URD 2025

View all LES ECHOS COMFI WIRE